At the end of September and beginning of October 2025 we will carry out two Ketamine-assisted Psychotherapy trainings together with Phil Wolfson.
Psilocybin and Depression Depression affects approximately 280 million people worldwide, making it a significant public health issue (1). Symptoms described in the Diagnostic and Statistical Manual of Mental Disorders include sadness, sleep disturbances, changes in appetite and energy levels, suicidal ideation, anhedonia, and diminished interest (2). A combination of both
How important is music in the sessions? We discuss it in this post
We discuss the use of ketamine to treat neuropathic pain
We talk about psilocybin and it’s therapeutic uses
New interview on YouTube with the researcher and psychologist José Carlos Bouso
We talk about fear and trauma, discussing the possible use of MDMA for the treatment of PTSD
Interview on youtube about ketamine-assisted psychotherapy in Ukraine
New interview on YouTube in which Phil tells us more about his career
What are some of the most common symptoms of clinical depression?
